CVR: 28310102
Previous names: BIOFIBER TØRRING ApS, BIODANE PHARMA ApS
DKK 2,534,166
Gross profit
Net result: DKK 182,862
BIODAN A/S
CVR · view ownership and management
Name registered: BIODANE PHARMA A/S
CVR · 06/10/2011
View the full event history
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named BIODANE PHARMA ApS and BIOFIBER TØRRING ApS. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity in the 2025 report amounted to DKK 2,505,002.
Source: annual report 2025, Danish Business Authority
The financial health of BIODANE PHARMA A/S appears stable, with a consistent gross profit trend over the past five years, peaking at 3,701,319 DKK in 2021 before declining to 2,534,166 DKK in 2025. Profitability has fluctuated, with a notable increase to 1,897,649 DKK in 2021, followed by a decrease to 182,862 DKK in 2025. The company's equity has decreased from a high of 4,642,518 DKK in 2022 to 2,505,002 DKK in 2025, indicating potential concerns regarding financial stability. Operating within the niche food manufacturing sector, BIODANE PHARMA's ability to maintain margins and manage equity will be crucial for its future trajectory.
AI-generated summary · Generated 13/08/2026
Selskabets formål er at drive virksomhed med handel, industri, håndværk og finansiering og anden i forbindelse hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 2.5 mio. | 183 t. | 3.7 mio. | 2.5 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | 2.9 mio. | 1.7 mio. | 3.4 mio. | 2.3 mio. | 1 | |
| 202301/01/2023 – 31/12/2023 | 3.1 mio. | 900 t. | 4.3 mio. | 3.5 mio. | 1 | |
| 202201/01/2022 – 31/12/2022 | 2.4 mio. | 586 t. | 5.4 mio. | 4.6 mio. | 1 | |
| 202101/01/2021 – 31/12/2021 | 3.7 mio. | 1.9 mio. | 5 mio. | 4.1 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | 1.6 mio. | 500 t. | 2.4 mio. | 2.2 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | 1.5 mio. | 257 t. | 1.8 mio. | 1.7 mio. | 1 | |
| 201801/01/2018 – 31/12/2018 | 1 mio. | -467 t. | 1.5 mio. | 1.4 mio. | 1 | |
| 201701/01/2017 – 31/12/2017 | 968 t. | 103 t. | 2.1 mio. | 1.9 mio. | 1 | |
| 201601/01/2016 – 31/12/2016 | 747 t. | 33 t. | 947 t. | 767 t. | 1 | |
| 201501/01/2015 – 31/12/2015 | 438 t. | -253 t. | 839 t. | 734 t. | - | |
| 201401/01/2014 – 31/12/2014 | 279 t. | -250 t. | 1.1 mio. | 987 t. | - | |
| 201301/01/2013 – 31/12/2013 | 106 t. | -977 t. | 607 t. | -263 t. | - | |
| 201201/01/2012 – 31/12/2012 | 384 t. | 8 t. | 1.2 mio. | 714 t. | - |
Compared to 169 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreBIODANE PHARMA A/S was founded on 29 December 2004.
BIODANE PHARMA A/S is registered under the industry Fremstilling af andre fødevarer i.a.n. (industry code 108900).
BIODANE PHARMA A/S is owned by BIODAN A/S.
biodanepharma.com belongs to BIODANE PHARMA A/S, CVR number 28310102.
In 2025, BIODANE PHARMA A/S reported a gross profit of DKK 2,534,166.
The management of BIODANE PHARMA A/S consists of Gunner Kreutzer Jakobsen.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 75557411, new website: https://biodanepharma.com/ (September 10, 2026).
As of September 1, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of BIODANE PHARMA A/S.
As of September 1, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of BIODANE PHARMA A/S.
BIODANE PHARMA A/S has published its annual report for 2025. Gross profit came to DKK 2,534,166, and the net result was DKK 182,862.
BIODANE PHARMA A/S has published its annual report for 2024. Gross profit came to DKK 2,886,145, and the net result was DKK 1,651,356.
BIODANE PHARMA A/S has published its annual report for 2023. Gross profit came to DKK 3,070,739, and the net result was DKK 900,246.
As of May 15, 2024, Peter Gæmelke has joined the board of directors of BIODANE PHARMA A/S.
As of May 15, 2024, Flemming Torben Heden Knudsen has joined the board of directors of BIODANE PHARMA A/S.
As of May 15, 2024, Lars Jørgen Larsen has left the board of directors of BIODANE PHARMA A/S.
As of March 4, 2024, Michael Prasanjit Baruah has left the board of directors of BIODANE PHARMA A/S.
BIODANE PHARMA A/S has published its annual report for 2022. Gross profit came to DKK 2,371,672, and the net result was DKK 586,354.
BIODANE PHARMA A/S has published its annual report for 2021. Gross profit came to DKK 3,701,319, and the net result was DKK 1,897,649.
BIODANE PHARMA A/S has published its annual report for 2020. Gross profit came to DKK 1,628,847, and the net result was DKK 499,535.
BIODANE PHARMA A/S has published its annual report for 2019. Gross profit came to DKK 1,508,453, and the net result was DKK 256,752.
BIODANE PHARMA A/S has published its annual report for 2018. Gross profit came to DKK 1,010,830, and the net result was DKK -467,077.
BIODANE PHARMA A/S has published its annual report for 2017. Gross profit came to DKK 967,640, and the net result was DKK 102,788.
BIODANE PHARMA A/S has published its annual report for 2016. Gross profit came to DKK 747,313, and the net result was DKK 32,975.
BIODANE PHARMA A/S has published its annual report for 2015. Gross profit came to DKK 437,995, and the net result was DKK -253,036.
BIODANE PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 278,919, and the net result was DKK -250,379.
BIODANE PHARMA A/S has published its annual report for 2013. Gross profit came to DKK 106,251, and the net result was DKK -976,558.
BIODANE PHARMA A/S has published its annual report for 2012. Gross profit came to DKK 384,418, and the net result was DKK 8,087.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BIODANE PHARMA A/S.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of BIODANE PHARMA A/S.
As of October 6, 2011, Michael Prasanjit Baruah has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Rasmus Juhl Rasmussen has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Lars Jørgen Larsen has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Gunner Kreutzer Jakobsen has joined the board of directors of BIODANE PHARMA A/S.
As of October 6, 2011, Gunner Kreutzer Jakobsen is registered as adm. dir. of BIODANE PHARMA A/S.
On October 6, 2011, the company changed its name from BIODANE PHARMA ApS to BIODANE PHARMA A/S.
On December 6, 2010, the company changed its name from BIOFIBER TØRRING ApS to BIODANE PHARMA ApS.
As of January 1, 2007, BIODAN A/S is registered as an owner of BIODANE PHARMA A/S with an ownership share of 100%.
As of December 29, 2004, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of BIODANE PHARMA A/S.
BIODANE PHARMA A/S was founded on December 29, 2004.
